Literature DB >> 7585148

The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain.

L Sun1, R Z Jiang, S Steinbach, A Holmes, C Campanelli, J Forstner, U Sajjan, Y Tan, M Riley, R Goldstein.   

Abstract

The rapid increase in Pseudomonas (Burkholderia) cepacia infection in cystic fibrosis (CF) patients suggests epidemic transmission, but the degree of transmissibility remains controversial as conflicting conclusions have been drawn from studies at different CF centres. This report provides the first DNA sequence-based documentation of a divergent evolutionary lineage of P. cepacia associated with CF centre epidemics in North America (Toronto) and Europe (Edinburgh). The involved epidemic clone encoded and expressed novel cable (Cbl) pili that bind to CF mucin. The sequence of the cblA pilin subunit gene carried by the epidemic isolates proved to be invariant. Although it remains to be determined how many distinct, highly transmissible lineages exist, our results provide both a DNA sequence and chromosomal fingerprint that can be used to screen for one such particularly infectious, transatlantic clone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585148     DOI: 10.1038/nm0795-661

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  76 in total

1.  Pseudomonas and all that.

Authors:  C A Hart; C Winstanley
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

Review 2.  Cystic fibrosis.

Authors:  P Robinson
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

Review 3.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 4.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 5.  Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Authors:  Melissa B Miller; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

6.  Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Authors:  Arlene D Vinion-Dubiel; Theodore Spilker; Charles R Dean; Henri Monteil; John J LiPuma; Joanna B Goldberg
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

7.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium.

Authors:  Teresa A Urban; Joanna B Goldberg; Janet F Forstner; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

9.  Quorum-sensing mutations affect attachment and stability of Burkholderia cenocepacia biofilms.

Authors:  Kerry L Tomlin; Rebecca J Malott; Gordon Ramage; Douglas G Storey; Pamela A Sokol; H Ceri
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 10.  The Evolution of Cystic Fibrosis Care.

Authors:  Jessica E Pittman; Thomas W Ferkol
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.